Literature DB >> 18230399

Rapid identification of reactive cysteine residues for site-specific labeling of antibody-Fabs.

Jagath R Junutula1, Sunil Bhakta, Helga Raab, Karen E Ervin, Charles Eigenbrot, Richard Vandlen, Richard H Scheller, Henry B Lowman.   

Abstract

Cysteines with reactive thiol groups are attractive tools for site-specific labeling of proteins. Engineering a reactive cysteine residue into proteins with multiple disulfide bonds is often a challenging task as it may interfere with structural and functional properties of the protein. Here we developed a phage display-based biochemical assay, PHESELECTOR (Phage ELISA for Selection of Reactive Thiols) to rapidly screen reactive thiol groups on antibody fragments without interfering with their antigen binding, using trastuzumab-Fab (hu4D5Fab) as a model system. The solvent accessibility values for all the amino acid residues in the hu4D5Fab were calculated using available crystal structure information. Serine, alanine and valine residues with highest solvent accessibility values were selected and tested to compare structure-based design with the PHESELECTOR biochemical method. Cysteine substitutions at partially solvent-accessible alanine or valine residues exhibited better thiol reactivity values than substitutions at serine residues. The poor correlation between fractional solvent accessibility and thiol reactivity of the engineered hu4D5Fab variants indicated the value of PHESELECTOR biochemical assay to identify reactive thiol groups on the antibody-Fab surface. Mass spectrometric analysis of biotinylated ThioFab (Fab with engineered cysteine) variants confirmed that conjugation occurred only at the engineered cysteine thiols of either light or heavy chains. ThioFabs with engineered cysteine residues in the constant domains (CL and CH(1)) should allow universal application for site-specific conjugation of antibody-Fabs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18230399     DOI: 10.1016/j.jim.2007.12.011

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  43 in total

1.  Synthesis of bispecific antibodies using genetically encoded unnatural amino acids.

Authors:  Chan Hyuk Kim; Jun Y Axup; Anna Dubrovska; Stephanie A Kazane; Benjamin A Hutchins; Erik D Wold; Vaughn V Smider; Peter G Schultz
Journal:  J Am Chem Soc       Date:  2012-06-06       Impact factor: 15.419

2.  Recent advances in the construction of antibody-drug conjugates.

Authors:  Vijay Chudasama; Antoine Maruani; Stephen Caddick
Journal:  Nat Chem       Date:  2016-01-04       Impact factor: 24.427

Review 3.  Advances in Antibody Design.

Authors:  Kathryn E Tiller; Peter M Tessier
Journal:  Annu Rev Biomed Eng       Date:  2015-08-14       Impact factor: 9.590

Review 4.  Pharmacokinetic considerations for antibody drug conjugates.

Authors:  Kedan Lin; Jay Tibbitts
Journal:  Pharm Res       Date:  2012-06-28       Impact factor: 4.200

5.  Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for THIOMAB™ Drug Conjugates.

Authors:  Siddharth Sukumaran; Kapil Gadkar; Crystal Zhang; Sunil Bhakta; Luna Liu; Keyang Xu; Helga Raab; Shang-Fan Yu; Elaine Mai; Aimee Fourie-O'Donohue; Katherine R Kozak; Saroja Ramanujan; Jagath R Junutula; Kedan Lin
Journal:  Pharm Res       Date:  2014-12-02       Impact factor: 4.200

6.  Site-Specific Fluorescent Labeling of Antibodies and Diabodies Using SpyTag/SpyCatcher System for In Vivo Optical Imaging.

Authors:  Md Kausar Alam; Ayman El-Sayed; Kris Barreto; Wendy Bernhard; Humphrey Fonge; C Ronald Geyer
Journal:  Mol Imaging Biol       Date:  2019-02       Impact factor: 3.488

7.  A platform for constructing, evaluating, and screening bioconjugates on the yeast surface.

Authors:  James A Van Deventer; Doris N Le; Jessie Zhao; Haixing P Kehoe; Ryan L Kelly
Journal:  Protein Eng Des Sel       Date:  2016-11-01       Impact factor: 1.650

8.  An improved single-chain Fab platform for efficient display and recombinant expression.

Authors:  James T Koerber; Michael J Hornsby; James A Wells
Journal:  J Mol Biol       Date:  2014-12-03       Impact factor: 5.469

Review 9.  Field Guide to Challenges and Opportunities in Antibody-Drug Conjugates for Chemists.

Authors:  Mallory R Gordon; Mine Canakci; Longyu Li; Jiaming Zhuang; Barbara Osborne; S Thayumanavan
Journal:  Bioconjug Chem       Date:  2015-09-10       Impact factor: 4.774

10.  Π-Clamp-mediated cysteine conjugation.

Authors:  Chi Zhang; Matthew Welborn; Tianyu Zhu; Nicole J Yang; Michael S Santos; Troy Van Voorhis; Bradley L Pentelute
Journal:  Nat Chem       Date:  2015-12-21       Impact factor: 24.427

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.